BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22617244)

  • 1. High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.
    Kadota K; Kachala SS; Nitadori J; Suzuki K; Dunphy MP; Sima CS; Travis WD; Rusch VW; Adusumilli PS
    J Thorac Oncol; 2012 Jul; 7(7):1192-7. PubMed ID: 22617244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.
    Kadota K; Suzuki K; Sima CS; Rusch VW; Adusumilli PS; Travis WD
    J Thorac Oncol; 2011 May; 6(5):896-904. PubMed ID: 21358344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.
    Lim JH; Choi JY; Im Y; Yoo H; Jhun BW; Jeong BH; Park HY; Lee K; Kim H; Kwon OJ; Han J; Ahn MJ; Kim J; Um SW
    PLoS One; 2020; 15(2):e0229299. PubMed ID: 32069313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of histological subtyping of malignant pleural mesothelioma.
    Brčić L; Jakopović M; Brčić I; Klarić V; Milošević M; Sepac A; Samaržija M; Seiwerth S
    Virchows Arch; 2014 Dec; 465(6):679-85. PubMed ID: 25300229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
    Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
    Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
    Genestreti G; Moretti A; Piciucchi S; Tiseo M; Bersanelli M; Scarlattei M; Scarpi E; Dubini A; Matteucci F; Sanna S
    Technol Cancer Res Treat; 2012 Apr; 11(2):163-7. PubMed ID: 22335410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.
    Kadota K; Villena-Vargas J; Nitadori J; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Ann Surg Oncol; 2015 Sep; 22(9):3136-43. PubMed ID: 25608772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.
    Tsutani Y; Takuwa T; Miyata Y; Fukuoka K; Hasegawa S; Nakano T; Okada M
    Ann Oncol; 2013 Apr; 24(4):1005-10. PubMed ID: 23136224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of pleural biopsy for the diagnosis of histologic subtype of malignant pleural mesothelioma: Necropsy-based study of 134 cases.
    Barbieri PG; Consonni D; Schneider M
    Tumori; 2022 Feb; 108(1):26-32. PubMed ID: 33719756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma.
    Abakay A; Komek H; Abakay O; Palanci Y; Ekici F; Tekbas G; Tanrikulu AC
    Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1233-41. PubMed ID: 23690193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
    Vigneswaran WT; Kircheva DY; Ananthanarayanan V; Watson S; Arif Q; Celauro AD; Kindler HL; Husain AN
    Ann Thorac Surg; 2017 Mar; 103(3):962-966. PubMed ID: 27765170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.
    Lee ST; Ghanem M; Herbertson RA; Berlangieri SU; Byrne AJ; Tabone K; Mitchell P; Knight SR; Feigen M; Scott AM
    Mol Imaging Biol; 2009; 11(6):473-9. PubMed ID: 19330385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pretreatment volume-based quantitative
    Kitajima K; Doi H; Kuribayashi K; Hashimoto M; Tsuchitani T; Tanooka M; Fukushima K; Nakano T; Hasegawa S; Hirota S
    Eur J Radiol; 2017 Jan; 86():176-183. PubMed ID: 28027744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
    Sharif S; Zahid I; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
    Meyerhoff RR; Yang CF; Speicher PJ; Gulack BC; Hartwig MG; D'Amico TA; Harpole DH; Berry MF
    J Surg Res; 2015 Jun; 196(1):23-32. PubMed ID: 25791825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?
    Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA
    Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T
    Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.
    Gill RR; Umeoka S; Mamata H; Tilleman TR; Stanwell P; Woodhams R; Padera RF; Sugarbaker DJ; Hatabu H
    AJR Am J Roentgenol; 2010 Aug; 195(2):W125-30. PubMed ID: 20651171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma.
    Lopci E; Novellis P; Testori A; Rahal D; Voulaz E; Bottoni E; Ferraroli GM; Crepaldi A; Ceresoli GL; Perrino M; Castello A; Alloisio M; Veronesi G; Zucali PA
    Nucl Med Commun; 2019 Nov; 40(11):1179-1186. PubMed ID: 31568271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma.
    Alchami FS; Attanoos RL; Bamber AR
    J Clin Pathol; 2017 Feb; 70(2):179-182. PubMed ID: 27798081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.